Literature DB >> 32297781

Strain and sex matters: Differences in nicotine self-administration between outbred and recombinase-driver transgenic rat lines.

Jonna M Leyrer-Jackson1, Paula F Overby1, Amanda Bull1, Julie A Marusich2, Cassandra D Gipson3.   

Abstract

Preclinical studies of nicotine self-administration provide important value for the field as they are highly rigorous, controlled, can be conducted quickly, and are generalizable to humans. Given the translational value of the nicotine self-administration model, and the relatively new guidelines of the National Institutes of Health to include sex as a biological variable, strain and sex differences in nicotine acquisition were examined here in two outbred rat strains. Sprague-Dawley (SD) and Long-Evans (LE; wildtype and cholinergic acetyltransferase cre-recombinase transgenic) rats of each sex were implanted with indwelling intravenous jugular catheters. Rats were trained to self-administer nicotine (0.02 mg/kg per infusion, paired with contingent light + tone stimuli). Acquisition criteria were set at a minimum active:inactive response ratio of 2:1 and a minimum of 10 infusions per session, both of which had to be met for a minimum of 10 sessions. Across 10 sessions, male SD rats self-administered significantly more nicotine than female SD rats (p < .05), indicating a sex difference in this strain. LE females self-administered more nicotine than SD females indicative of a strain difference between females (p < .05). SD males increased nicotine infusions across sessions compared to LE males and SD females (p < .05). No strain or sex differences were observed in the number of sessions to reach criteria. No differences between wildtype and transgenic LE rats were observed. These results demonstrate sex and strain differences in nicotine self-administration between SD and LE rats and may lend insight into development of other nicotine self-administration models, where sex and strain may impact acquisition. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32297781      PMCID: PMC8375641          DOI: 10.1037/pha0000376

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.492


  55 in total

Review 1.  Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits.

Authors:  Huibert D Mansvelder; Marjolijn Mertz; Lorna W Role
Journal:  Semin Cell Dev Biol       Date:  2009-01-22       Impact factor: 7.727

2.  Escalation of cocaine intake with extended access in rats: dysregulated addiction or regulated acquisition?

Authors:  Joshua S Beckmann; Cassandra D Gipson; Julie A Marusich; Michael T Bardo
Journal:  Psychopharmacology (Berl)       Date:  2012-01-17       Impact factor: 4.530

3.  Propensity for social interaction predicts nicotine-reinforced behaviors in outbred rats.

Authors:  T Wang; W Han; B Wang; Q Jiang; L C Solberg-Woods; A A Palmer; H Chen
Journal:  Genes Brain Behav       Date:  2013-12-27       Impact factor: 3.449

4.  Gender effects on mood and cigarette craving during early abstinence and resumption of smoking.

Authors:  Jiansong Xu; Allen Azizian; John Monterosso; Catherine P Domier; Arthur L Brody; Timothy W Fong; Edythe D London
Journal:  Nicotine Tob Res       Date:  2008-11       Impact factor: 4.244

5.  Effects of nicotine self-administration on incentive salience in male Sprague Dawley rats.

Authors:  Paula F Overby; Carter W Daniels; Armani Del Franco; Julianna Goenaga; Gregory L Powell; Cassandra D Gipson; Federico Sanabria
Journal:  Psychopharmacology (Berl)       Date:  2018-01-26       Impact factor: 4.530

Review 6.  The scientific case that nicotine is addictive.

Authors:  I P Stolerman; M J Jarvis
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

Review 7.  Epigenetic mechanisms of drug addiction.

Authors:  Eric J Nestler
Journal:  Neuropharmacology       Date:  2013-04-30       Impact factor: 5.250

Review 8.  Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction.

Authors:  Huibert D Mansvelder; Mischa De Rover; Daniel S McGehee; Arjen B Brussaard
Journal:  Eur J Pharmacol       Date:  2003-11-07       Impact factor: 4.432

Review 9.  Sex as an important biological variable in biomedical research.

Authors:  Suk Kyeong Lee
Journal:  BMB Rep       Date:  2018-04       Impact factor: 4.778

10.  Chronic treatment with N-acetylcysteine decreases extinction responding and reduces cue-induced nicotine-seeking.

Authors:  Gregory L Powell; Jonna M Leyrer-Jackson; Julianna Goenaga; Mark D Namba; Jose Piña; Sade Spencer; Neringa Stankeviciute; Danielle Schwartz; Nicholas P Allen; Armani P Del Franco; Erin A McClure; Michael Foster Olive; Cassandra D Gipson
Journal:  Physiol Rep       Date:  2019-01
View more
  4 in total

1.  Natural and synthetic estrogens specifically alter nicotine demand and cue-induced nicotine seeking in female rats.

Authors:  Erin E Maher; Paula F Overby; Amanda H Bull; Joshua S Beckmann; Jonna M Leyrer-Jackson; Stephanie V Koebele; Heather A Bimonte-Nelson; Cassandra D Gipson
Journal:  Neuropharmacology       Date:  2021-08-17       Impact factor: 5.273

2.  Accumbens Cholinergic Interneurons Mediate Cue-Induced Nicotine Seeking and Associated Glutamatergic Plasticity.

Authors:  Jonna M Leyrer-Jackson; Michael Holter; Paula F Overby; Jason M Newbern; Michael D Scofield; M Foster Olive; Cassandra D Gipson
Journal:  eNeuro       Date:  2021-02-09

Review 3.  Sex Differences in the Nicotinic Acetylcholine Receptor System of Rodents: Impacts on Nicotine and Alcohol Reward Behaviors.

Authors:  Janna K Moen; Anna M Lee
Journal:  Front Neurosci       Date:  2021-09-21       Impact factor: 4.677

4.  Nicotine self-administration and ERK signaling are altered in RasGRF2 knockout mice.

Authors:  Ilaria Morella; Veronika Pohořalá; Claudia Calpe-López; Riccardo Brambilla; Rainer Spanagel; Rick E Bernardi
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.